Health
FDA Approves Monthly Injectable HIV Drug Combo – Star Observer
The United States Food and Drug Administration on Thursday approved Cabenuva, for the treatment of HIV in adults.
The United States Food and Drug Administration on Thursday approved Cabenuva, a once a month injectable drug combination with cabotegravir and rilpivirine, for the treatment of HIV in adults.
Currently, the standard of care for patients with HIV includes patients taking daily pills to adequately manage their condition. This approval will allow some patients the option of receiving once-monthly injections in lieu of a daily oral treatment regimen, said Dr. John Farley, director of the Office of…
Continue Reading
